NCT04591938View on ClinicalTrials.gov

FANTOM ENCORE Sirolimus-eluting Bioresorbable Scaffold for Treatment of De-novo CAD: the ENCORE-I Study

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

June 1, 2021

Study Completion Date

December 31, 2025

Conditions
Percutaneous Coronary InterventionMyocardial RevascularizationTomography, Optical Coherence
Interventions
DEVICE

Fantom Encore Bioresorbable scaffold implantation

Fantom Encore Bioresorbable scaffold implantation

Trial Locations (3)

Unknown

NOT_YET_RECRUITING

Ziekenhuis Oost-Limburg, Genk

NOT_YET_RECRUITING

Universitair Ziekenhuis Leuven, Leuven

RECRUITING

Erasmus Medical Center, Rotterdam

All Listed Sponsors
collaborator

Horizon 2020 - European Commission

OTHER

collaborator

REVA Medical, Inc.

INDUSTRY

lead

Joost Daemen

OTHER